# NUVOX PHARMA, LLC: Liquid Biopsy in Glioblastoma Treated with Chemoradiation and an Oxygen Therapeutic

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | NUVOX PHARMA, LLC |
| Location | TUCSON, AZ |
| Project | Liquid Biopsy in Glioblastoma Treated with Chemoradiation and an Oxygen Therapeutic |
| Project number | 5R44CA298498-02 |
| Mechanism | R44 |
| Institute | National Cancer Institute |
| Award | $1,057,531 |
| Awarded | 2026-08-27 |
| Project period | 2025-09-22 to 2027-08-31 |
| UEI | WHNYG96UDLJ8 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11420569). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.